CARDIAC FIBROBLASTS ARREST AT THE G1 S RESTRICTION POINT IN RESPONSE TO INTERLEUKIN (IL)-1-BETA - EVIDENCE FOR IL-1-BETA-INDUCED HYPOPHOSPHORYLATION OF THE RETINOBLASTOMA PROTEIN/

Citation
F. Koudssi et al., CARDIAC FIBROBLASTS ARREST AT THE G1 S RESTRICTION POINT IN RESPONSE TO INTERLEUKIN (IL)-1-BETA - EVIDENCE FOR IL-1-BETA-INDUCED HYPOPHOSPHORYLATION OF THE RETINOBLASTOMA PROTEIN/, The Journal of biological chemistry, 273(40), 1998, pp. 25796-25803
Citations number
99
Categorie Soggetti
Biology
ISSN journal
00219258
Volume
273
Issue
40
Year of publication
1998
Pages
25796 - 25803
Database
ISI
SICI code
0021-9258(1998)273:40<25796:CFAATG>2.0.ZU;2-D
Abstract
Although responsible for only approximately one-third of the overall m yocardial mass, the interstitial fibroblasts of the heart serve a fund amental role in establishing the functional integrity of myocardium an d are the major source of myocardial extracellular matrix production. Their importance in clinical medicine is underscored by the observatio n that fibroblast numbers increase in response to several pathologic c ircumstances that are associated with an increase in extracellular mat rix production such as long standing hypertension and myocardial injur y/infarction. Up to the present time, however, there has been little i nformation available on either the kinetics of the cardiac fibroblast cell cycle, or the fundamental mechanisms that regulate its entry into and exit from the cell cycle. Previous work from our laboratory exami ning the effects of interleukin (IL)-1 beta on myocardial growth and g ene expression in culture indicated that cardiac fibroblasts have a di minished capacity to synthesize DNA in response to mitogen in the pres ence of this cytokine. The mechanism of IL-1 beta action was not clear , however, and could have resulted from action at several different po ints in the cell cycle, The investigations described in this report in dicate that IL-1 beta exerts its effect on the fibroblast cell cycle a t multiple levels through altering the expression of cardiac fibroblas t cyclins, cyclin-dependent kinases, and their inhibitors, which ultim ately affect the phosphorylation of the retinoblastoma gene product.